MTX agent, Alginate-PEG-methotrexate, Purity ≥95%

Cat. No.: X25-04-YM1063

MTX agent, Alginate-PEG-methotrexate, Purity ≥95%

Synonym: Methotrexate-PEG-alginate

Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Sub Cat. No. Molecular Weight Glycan Name Functional Group Inquiry
X25-04-YM1063-1 PEG 350 Da Alginate MTX Inquiry
X25-04-YM1063-2 PEG 550 Da Alginate MTX Inquiry
X25-04-YM1063-3 PEG 750 Da Alginate MTX Inquiry
X25-04-YM1063-4 PEG 1 kDa Alginate MTX Inquiry
X25-04-YM1063-5 PEG 2 kDa Alginate MTX Inquiry
X25-04-YM1063-6 PEG 3 kDa Alginate MTX Inquiry
X25-04-YM1063-7 PEG 4 kDa Alginate MTX Inquiry
X25-04-YM1063-8 PEG 5 kDa Alginate MTX Inquiry
X25-04-YM1063-9 PEG 10 kDa Alginate MTX Inquiry
X25-04-YM1063-10 PEG 20 kDa Alginate MTX Inquiry
Properties
Description
Alginate-PEG-methotrexate (MTX-PEG-alginate) connects alginate to methotrexate via PEG. Variable PEG (350–20k Da) enhances solubility, prolongs exposure, and controls chemotherapeutic release.
Source
Chemical synthesis
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Stability
It is stable under its storage temperature.
Quality Level
Research level
Applications
Alginate-PEG-methotrexate plays a key role in studying platinum-DNA adduct formation in controlled release systems.
Storage
Store at -20°C, protect from light and moisture.
For Research Use Only. Not For Clinical Use.

Contact Us
Top